JBM (Healthcare) Limited (HKG:2161)
Hong Kong
· Delayed Price · Currency is HKD 2.800
+0.090 (3.32%)
Mar 10, 2026, 3:57 PM HKT
JBM (Healthcare) Revenue
JBM (Healthcare) had revenue of 429.64M HKD in the half year ending September 30, 2025, with 31.46% growth. This brings the company's revenue in the last twelve months to 812.98M, up 12.83% year-over-year. In the fiscal year ending March 31, 2025, JBM (Healthcare) had annual revenue of 782.29M with 20.65% growth.
Revenue (ttm)
812.98M
Revenue Growth
+12.83%
P/S Ratio
2.72
Revenue / Employee
1.97M
Employees
412
Market Cap
2.21B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Golden Throat Holdings Group Company | 1.07B |
| Essex Bio-Technology | 1.72B |
| Jacobson Pharma Corporation | 1.53B |
| Dawnrays Pharmaceutical (Holdings) | 1.22B |
| Hua Medicine (Shanghai) | 406.16M |
| VISEN Pharmaceuticals | 921.55K |
| Chia Tai Enterprises International | 4.17B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.02B |